Sign in to view content

Should We Ever Consider Stopping Treatment for Neovascular AMD?

Rahul N. Khurana, MD, FASRS

Video
Published 2020

Related

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Pradeepa Yoganathan Last Word
Pradeepa Yoganathan, MSc, MD, FRCS(C)
Annual Meeting Talks

Category: Age-Related Macular Degeneration

See more